UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients

Clinical & translational oncology, 2018-04, Vol.20 (4), p.484-490

2018

Volltextzugriff (PDF)

PO-0784: Rectal tumor volume shrinkage evaluated with MRI during preoperative chemoradiotherapy

Radiotherapy and oncology, 2015-04, Vol.115, p.S391-S392

2015

Volltextzugriff (PDF)

PV-0323: Prospective evaluation of markerless tumour tracking using 4D3D registration and dual energy imaging

Radiotherapy and oncology, 2016-04, Vol.119, p.S148-S149

2016

Volltextzugriff (PDF)

PO-0791: Motion management and Vero dynamic tracking for SBRT in oligometastatic disease: a prospective trial

Radiotherapy and oncology, 2016-04, Vol.119, p.S372-S372

2016

Volltextzugriff (PDF)

PO-0777: Patterns of local failure after SBRT for oligometastatic colorectal cancer

Radiotherapy and oncology, 2014, Vol.111, p.S50-S50

2014

Volltextzugriff (PDF)

PD-0515: Phase II study of VERO SBRT for oligometastatic cancer: First clinical results

Radiotherapy and oncology, 2014, Vol.111, p.S203-S203

2014

Volltextzugriff (PDF)

PO-1076 Implementation of the 1.5T MR-linac: healthy volunteers, screen recording and initial experience

Radiotherapy and oncology, 2023-05, Vol.182, p.S860-S861

2023

Volltextzugriff (PDF)

PH-0375 Lymphocyte-sparing in pelvic radiotherapy for prostate cancer: an in-silico planning study

Radiotherapy and oncology, 2021-08, Vol.161, p.S273-S274

2021

Volltextzugriff (PDF)

PO-1860 Physical vs. biological based VMAT optimization for prostate cancer radiotherapy

Radiotherapy and oncology, 2021-08, Vol.161, p.S1584-S1585

2021

Volltextzugriff (PDF)

PO-1185 Targeting therapy-resistant metastatic clones with SBRT in oligoprogressive breast cancer

Radiotherapy and oncology, 2022-05, Vol.170, p.S1005-S1005

2022

Volltextzugriff (PDF)

The METABANK Score: A Clinical Tool to Predict Survival after Stereotactic Radiation Therapy for Oligometastatic Disease

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.e370-e370

2018

Volltextzugriff (PDF)

OC-0625 Immuno-radiotherapy in solid tumors: preliminary results of the randomized phase 2 CHEERS trial

Radiotherapy and oncology, 2021-08, Vol.161, p.S490-S491

2021

Volltextzugriff (PDF)

The Regression of Rectal Tumors During Preoperative Chemoradiation Therapy: A Prospective Study With Weekly MRI

International journal of radiation oncology, biology, physics, 2017-10, Vol.99 (2), p.E195-E195

2017

Volltextzugriff (PDF)

84TiP Neo-CheckRay: Radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer: A randomized phase II trial

Annals of oncology, 2020-12, Vol.31, p.S1451-S1451

2020

Volltextzugriff (PDF)

The concept of « oligometastases » and stereotactic body radiotherapy

Revue médicale de Bruxelles, 2022, Vol.43 (3), p.218-226

2022

Volltextzugriff (PDF)

MRI-Linac: the beginning of a new era of personalized medicine in radiotherapy

Revue médicale de Bruxelles, 2022, Vol.43 (6), p.588-591

2022

Volltextzugriff (PDF)

PO-0996: Dynamic Wave Arc for lung SBRT: compliance with RTOG dosimetric criteria

Radiotherapy and oncology, 2018-04, Vol.127, p.S554-S555

2018

Volltextzugriff (PDF)

PO-0677: Vero SBRT for early stage lung cancer: a phase II trial with dynamic tracking in selected lesions

Radiotherapy and oncology, 2017-05, Vol.123, p.S354-S354

2017

Volltextzugriff (PDF)

OC-0484: Variability of breathing-induced tumour motion: 4DCT – a source of misguiding information?

Radiotherapy and oncology, 2017-05, Vol.123, p.S256-S257

2017

Volltextzugriff (PDF)

OC-0439: Treating patients with Dynamic Wave Arc: first clinical experience

Radiotherapy and oncology, 2017-05, Vol.123, p.S231-S232

2017

Volltextzugriff (PDF)

900TiPA phase II randomized, open-label study comparing salvage radiotherapy in combination with 6 months of androgen-deprivation therapy with LHRH agonist or antagonist versus anti-androgen therapy with apalutamide in patients with biochemical progression after radical prostatectomy

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Kollektion

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients

PO-0784: Rectal tumor volume shrinkage evaluated with MRI during preoperative chemoradiotherapy

PV-0323: Prospective evaluation of markerless tumour tracking using 4D3D registration and dual energy imaging

PO-0791: Motion management and Vero dynamic tracking for SBRT in oligometastatic disease: a prospective trial

PO-0777: Patterns of local failure after SBRT for oligometastatic colorectal cancer

PD-0515: Phase II study of VERO SBRT for oligometastatic cancer: First clinical results

PO-1076 Implementation of the 1.5T MR-linac: healthy volunteers, screen recording and initial experience

PH-0375 Lymphocyte-sparing in pelvic radiotherapy for prostate cancer: an in-silico planning study

PO-1860 Physical vs. biological based VMAT optimization for prostate cancer radiotherapy

PO-1185 Targeting therapy-resistant metastatic clones with SBRT in oligoprogressive breast cancer

The METABANK Score: A Clinical Tool to Predict Survival after Stereotactic Radiation Therapy for Oligometastatic Disease

OC-0625 Immuno-radiotherapy in solid tumors: preliminary results of the randomized phase 2 CHEERS trial

The Regression of Rectal Tumors During Preoperative Chemoradiation Therapy: A Prospective Study With Weekly MRI

84TiP Neo-CheckRay: Radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer: A randomized phase II trial

The concept of « oligometastases » and stereotactic body radiotherapy

MRI-Linac: the beginning of a new era of personalized medicine in radiotherapy

PO-0996: Dynamic Wave Arc for lung SBRT: compliance with RTOG dosimetric criteria

PO-0677: Vero SBRT for early stage lung cancer: a phase II trial with dynamic tracking in selected lesions

A phase II randomized, open-label study comparing salvage radiotherapy in combination with 6 months of androgen-deprivation therapy with LHRH agonist or antagonist versus anti-androgen therapy with apalutamide in patients with biochemical progression after radical prostatectomy

900TiP - A phase II randomized, open-label study comparing salvage radiotherapy in combination with 6 months of androgen-deprivation therapy with LHRH agonist or antagonist versus anti-androgen therapy with apalutamide in patients with biochemical progression after radical prostatectomy

OC-0484: Variability of breathing-induced tumour motion: 4DCT – a source of misguiding information?

OC-0439: Treating patients with Dynamic Wave Arc: first clinical experience

900TiPA phase II randomized, open-label study comparing salvage radiotherapy in combination with 6 months of androgen-deprivation therapy with LHRH agonist or antagonist versus anti-androgen therapy with apalutamide in patients with biochemical progression after radical prostatectomy

Suchergebnisse filtern